Aspen Aerogels Inc (ASPN): R&D Expense

Annual figures by period end, from SEC filings.

$13.42M
Year ended 2025-12-31
$11.21M
Trailing 12 months to 2026-06-30
-7.5%
3-year compound annual growth
+9.0%
5-year compound annual growth
+9.8%
10-year compound annual growth
$18.05M2012-12-31: $5.14M2013-12-31: $5.16M2014-12-31: $5.98M2015-12-31: $5.25M2016-12-31: $5.31M2017-12-31: $6.18M2018-12-31: $6.32M2019-12-31: $8.41M2020-12-31: $8.73M2021-12-31: $11.44M2022-12-31: $16.93M2023-12-31: $16.36M2024-12-31: $18.05M2025-12-31: $13.42M$13.42M
2012-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$13.42M-25.7%2026-03-23, From 2025-01-01
2024-12-31$18.05M+10.4%2026-03-23, From 2024-01-01
2023-12-31$16.36M-3.4%2026-03-23, From 2023-01-01
2022-12-31$16.93M+48.0%2025-02-27, From 2022-01-01
2021-12-31$11.44M+31.1%2024-03-07, From 2021-01-01
2020-12-31$8.73M+3.8%2023-03-16, From 2020-01-01
2019-12-31$8.41M+33.0%2022-03-01, From 2019-01-01
2018-12-31$6.32M+2.2%2021-03-12, From 2018-01-01
2017-12-31$6.18M+16.5%2020-03-06, From 2017-01-01
2016-12-31$5.31M+1.0%2019-03-08, From 2016-01-01
2015-12-31$5.25M-12.2%2018-03-01, From 2015-01-01
2014-12-31$5.98M+15.9%2017-03-02, From 2014-01-01
2013-12-31$5.16M+0.3%2016-03-04, From 2013-01-01
2012-12-31$5.14Mn/a2015-03-13, From 2012-01-01